National Guideline Clearinghouse | Palliative radiotherapy. Ovarian Cancer and Us OVARIAN CANCER and US Ovarian Cancer and Us

Blog Archives: Nov 2004 - present

#ovariancancers



Special items: Ovarian Cancer and Us blog best viewed in Firefox

Search This Blog

Monday, May 07, 2012

National Guideline Clearinghouse | Palliative radiotherapy.



Blogger's Note: the document reveals only one indication for ovarian cancer and it has been categorized under urogenital bleeding

National Guideline Clearinghouse | Palliative radiotherapy.

Guideline Objective(s)

To provide recommended palliative radiotherapy strategies for adult patients with advanced cancer

Scope  

Disease/Condition(s)


Advanced cancer with:
  • Brain metastases
  • Malignant epidural spinal cord compression
  • Malignant superior vena cava obstruction
  • Bone metastases
  • Upper aero-digestive tract obstruction, compression, or invasion
  • Malignancy-associated urogenital or gastrointestinal bleeding, or hemoptysis
Guideline Category
Management Treatment
Clinical Specialty
Gastroenterology Neurological Surgery Obstetrics and Gynecology Oncology Pulmonary Medicine Radiation Oncology Urology



Bleeding
Recommendations for Urogenital Bleeding
  1. External beam radiotherapy has been shown to control hematuria in up to 60 percent of patients with advanced bladder cancer; and control rates of 80 percent at six weeks have recently been reported in patients with advanced prostate cancer. In patients with a life expectancy less than six months, external beam radiotherapy treatment with 8 Gy/1 fraction could be considered. Otherwise, a short course multi-fraction schedule could be considered.
  2. In patients with vaginal bleeding who are unsuitable for radical treatment, radiotherapy is effective in resolving bleeding secondary to endometrial or cervical cancer. There is insufficient evidence to recommend an ideal dose and fractionation schedule. Radiotherapy may also be used to control bleeding and palliate pain and mass effect in advanced ovarian cancer.  

0 comments :

Post a Comment

Your comments?

Note: Only a member of this blog may post a comment.